|
顯示項目 539981-539990 / 2348419 (共234842頁)
<< < 53994 53995 53996 53997 53998 53999 54000 54001 54002 54003 > >>
每頁顯示[10|25|50]項目
| 國立臺灣科技大學 |
2018 |
Kraft lignin biorefinery: A perspective
|
Hu, J.;Zhang, Q.;Lee, D.-J. |
| 嘉南藥理大學 |
2009 |
Krankenhaus-Hygiene + Infektionsverh�
|
Elsevier SDOL |
| 國立臺灣大學 |
2015 |
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation
|
Serrano, Cesar; Wang, Yuexiang; Marino-Enriquez, Adrian; Lee, Jen-Chieh; Ravegnini, Gloria; Morgan, Jeffrey A.; Bertagnolli, Monica M.; Beadling, Carol; Demetri, George D.; Corless, Christopher L.; Heinrich, Michael C.; Fletcher, Jonathan A.; 李仁傑 |
| 臺大學術典藏 |
2018-09-10T15:28:15Z |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano, C. and Wang, Y. and Mari\\~no-Enr\\'iquez, A. and Lee, J.-C. and Ravegnini, G. and Morgan, J.A. and Bertagnolli, M.M. and Beadling, C. and Demetri, G.D. and Corless, C.L. and Heinrich, M.C. and Fletcher, J.A.; JEN-CHIEH LEE |
| 臺大學術典藏 |
2020-03-07T06:52:12Z |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano C.;Wang Y.;Mariño-Enríquez A;Jen-Chieh Lee;Ravegnini G.;Morgan J.A.;Bertagnolli M.M.;Beadling C.;Demetri G.D.;Corless C.L.;Heinrich M.C.;Fletcher J.A.; Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. |
| 臺大學術典藏 |
2015 |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano C.; Wang Y.; Mari?o-Enr?quez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. |
| 國立成功大學 |
2017-07-26 |
KRAS Gene Mutations在大腸直腸癌肝轉移中扮演的角色
|
林鵬展; Lin, Peng-Chan |
| 臺大學術典藏 |
2018-09-10T09:22:43Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Ou, Da-Liang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Ou, D.-L. and Lin, L.-I. and Tseng, L.-H. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; Lin, Yu-Lin; LI-HUI TSENG; Lin, Yu-Lin; Liau, Jau-Yu; YIH-LEONG CHANG; JAU-YU LIAU; Yu, Shan-Chi; Ou, Da-Liang; DA-LIANG OU; Ou, Da-Liang; LIANG-IN LIN; Lin, Liang-In; Lin, Liang-In; Tseng, Li-Hui; KUN-HUEI YEH; Tseng, Li-Hui; Chang, Yih-Leong; YU-LIN LIN; Yeh, Kun-Huei; ANN-LII CHENG; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Cheng, Ann-Lii |
| 臺大學術典藏 |
2012 |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Yeh K.-H.; Cheng A.-L.; YIH-LEONG CHANG; Lin L.-I.; Tseng L.-H.; Yu S.-C.; Ou D.-L.; Liau J.-Y.; Lin Y.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:45Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
顯示項目 539981-539990 / 2348419 (共234842頁)
<< < 53994 53995 53996 53997 53998 53999 54000 54001 54002 54003 > >>
每頁顯示[10|25|50]項目
|
